Ładuje się......
Pharmacological mechanism of roflumilast in the treatment of asthma–COPD overlap
Asthma–COPD overlap (ACO) is a type of incomplete obstructive airway disease that has a high incidence and mortality. Nevertheless, there is currently no clear definition of ACO and no effective intervention. The newly discovered phosphodiesterase-4 inhibitor, roflumilast, has shown initial efficacy...
Zapisane w:
| Wydane w: | Drug Des Devel Ther |
|---|---|
| Główni autorzy: | , , , , , , , , , |
| Format: | Artigo |
| Język: | Inglês |
| Wydane: |
Dove Medical Press
2018
|
| Hasła przedmiotowe: | |
| Dostęp online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6078181/ https://ncbi.nlm.nih.gov/pubmed/30122895 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/DDDT.S165161 |
| Etykiety: |
Dodaj etykietę
Nie ma etykietki, Dołącz pierwszą etykiete!
|